Nephrologists: CKD in T2D Pill | CKD in T2D Amplifies CV Risk
广告View A Cardiorenal Therapy For CKD in T2D That Delays CKD Progression In Patients. A…Mechanism of Action · FDA-Approved Treatment · Dosing Information · Safety Information
Types: Downloadable Resources, Case Study Videos, Clinical Trial DataFABHALTA® (iptacopan) | Official Physician Site
广告FABHALTA® (iptacopan). View Full Safety, Prescribing Information, And Boxed Warning. …HCP Resources · Phase 3 Study Results · Safety & Efficacy Info · Learn More Today
Types: PA And Appeals Kit, Starting FABHALTA® Guide, HCP Resources

反馈